Please enable JS

ARTICLES & TESTIMONIALS

More States Demand Notification to Use Biosimilar Drugs

Mar 30// Advocates in the news GHLF in the news

Without the medicine Rachelle Crow takes for her rheumatoid arthritis, the 29-year-old Michigan woman’s face would frequently feel as if it were engulfed in flames. She would barely be able to crawl out of bed. She would have trouble opening or closing her fists or lifting her 3-year-old daughter. Crow can do all those things […]

READ MORE

Washington State House of Representatives Health Care & Wellness Committee

Mar 24// Letters and Testimony

TESTIMONY – STATE BIOSIMILAR SUBSTITUTION Washington State House of Representatives Health Care & Wellness Committee House Health Care & Wellness Committee consideration of SB 5935 Speaker: Lisa Powell Patient Advocate Global Healthy Living Foundation March 24, 2015 Disclosure: I have no disclosures to make regarding my travel here today. The Global Healthy Living Foundation accepts grants […]

READ MORE

Houston Chronicle – Soaring specialty drug prices leave patients seeking relief

Mar 23// Advocates in the news GHLF in the news

Julie Wiles of Spring says she found relief from rheumatoid arthritis when she began receiving injections of Enbrel, a drug that costs $2,500 a week. But even with insurance coverage, Wiles can no longer afford Enbrel. Instead, she takes a combination of less expensive drugs and injections that hasn’t been nearly as effective.   Read […]

READ MORE

The Washington Post – Biologics are revolutionizing care for some diseases, but they are very costly

Mar 23// Advocates in the news

Mariah Leach felt at the top of her game six years ago. At age 25, she was pursuing a law degree and a master’s in environmental policy at the University of Colorado, earning straight A’s and playing water polo with the university’s club team. But then her toes began to hurt. A few weeks, later […]

READ MORE

Oregon House of Representatives Committee on Health Care

Mar 16// Letters and Testimony

TESTIMONY – STATE BIOSIMILAR SUBSTITUTION Oregon House of Representatives Committee on Health Care  Committee on Health Care consideration of HB 2026  Speaker: Anna Marie Meyer Patient Advocate Global Healthy Living Foundation March 16, 2015 Disclosure: I have no disclosures to make regarding my travel here today. The Global Healthy Living Foundation accepts grants and charitable contributions […]

READ MORE

Medical Marketing & Media – Biosimilar uptake will require companies to tell a trustworthy backstory

Mar 12// GHLF in the news

Novartis still has to win a patent-infringement lawsuit before it can sell Zarxio, the first biosimilar to receive FDA approval, but experts and advocates indicate the potential rollout of the drug is less important than the fact that the approval has smoothed the way for the four biosimilar applications in front of the FDA. Read […]

READ MORE

International Business Times – Generic Biologics? After FDA Approves First Biosimilar Drug, Education, Clearer Policies Needed, Experts Say

Mar 11// Advocates in the news GHLF in the news

Last year, when Mariah Leach was pregnant with her son, her rheumatoid arthritis flared up again. She had stopped medication during pregnancy, but when the autoimmune disease, which causes painful and damaging inflammation in joints and elsewhere, resurged, she and her doctors made the difficult decision for her to restart during her third trimester, based […]

READ MORE

Medical News – Positive impact: When considering ‘biosimilars’ legislation, Kentucky must ensure patient safety.

Mar 11// GHLF in the news

The positive impact of biologic medicines for the treatment of many chronic diseases, such as multiple sclerosis, HIV, hepatitis C, Rheumatoid arthritis and others, cannot be understated.  That’s why it’s good news that soon patients and prescribers will have access to cutting edge medicines called biosimilars. Read More

READ MORE

LA Times: FDA approves knockoff of Amgen’s Neupogen chemo recovery drug

Mar 10// Advocates in the news

Mariah Leach, 32, a Colorado woman who uses biologics to treat rheumatoid arthritis, said she hopes pharmacies and insurers don’t force her to take a biosimilar version. “The opportunity to have a less expensive treatment option is fabulous,” she said. “I just don’t want to be put on it without my choice. I don’t want […]

READ MORE